Hematopoietic Stem Cell TransplantationSpleenTransplantation, HomologousStem Cell TransplantationTransplantation, AutologousLiver TransplantationTransplantation ConditioningBone Marrow TransplantationPeripheral Blood Stem Cell TransplantationGraft vs Host DiseaseKidney TransplantationCell TransplantationGraft SurvivalHeart TransplantationHematologic NeoplasmsTransplantation ChimeraTissue DonorsLung TransplantationTreatment OutcomeCord Blood Stem Cell TransplantationTransplantation ImmunologyGraft RejectionImmunosuppressive AgentsOrgan TransplantationImmunosuppressionIslets of Langerhans TransplantationT-LymphocytesHistocompatibility TestingWhole-Body IrradiationMyeloablative AgonistsTransplantation, IsogeneicHistocompatibilityTransplantationRetrospective StudiesTime FactorsRecurrenceMesenchymal Stem Cell TransplantationPancreas TransplantationBusulfanMice, Inbred BALB CMice, Inbred C57BLAntilymphocyte SerumCombined Modality TherapyMice, Inbred StrainsMultiple MyelomaRemission InductionLymphocyte TransfusionMelphalanSurvival AnalysisLiving DonorsCyclophosphamideSurvival RateLeukemiaGraft vs Leukemia EffectAntibody FormationVidarabineTransplantation ToleranceDisease-Free SurvivalLymphocytesHLA AntigensFollow-Up StudiesHemolytic Plaque TechniqueTransplantation, HeterotopicConcanavalin ACells, CulturedGraft vs Tumor EffectGraft vs Host ReactionLymphocyte DepletionChimerismLymphocyte ActivationLeukemia, Myeloid, AcuteHeart-Lung TransplantationUnrelated DonorsCyclosporineHepatic Veno-Occlusive DiseaseImmune ToleranceImmunization, PassiveMice, Inbred C3HTissue and Organ ProcurementAntineoplastic Combined Chemotherapy ProtocolsSiblingsHematopoietic Stem CellsHematopoietic Stem Cell MobilizationFetal Tissue TransplantationTransplantation, HeterologousSalvage TherapyAntibodies, MonoclonalB-LymphocytesCytomegalovirus InfectionsThymus GlandHematologic DiseasesAcute DiseaseBone Marrow CellsMice, Inbred CBADonor SelectionLymphoma, Non-HodgkinImmunity, CellularMyelodysplastic SyndromesLiver FailureAntibody-Producing Cells